biomarkers
biomarkers
-
Chinese Medicine Obesity Research Advances Through Biomarker Driven Trial Designs
Advances in Chinese medicine obesity research now prioritize biomarker-driven trial designs—boosting validity, reproducibility, and clinical translation.
2026-03-27
-
Chinese Medicine Obesity Research Identifies Key Biomarkers for Treatment Response
New clinical research identifies 3 predictive biomarkers for TCM obesity treatment response — backed by multi-center data and real-world outcomes.
2026-03-23
-
Chinese Medicine Obesity Research Identifies Key Biomarkers in Metabolic Syndrome
New TCM obesity research identifies adiponectin, LRI, and TMAO as key metabolic syndrome biomarkers—with clinical validation across 1,243 patients.
2026-03-18
-
TCM Weight Loss Clinical Trials Integrate Traditional Pattern Differentiation With Biomarkers
Evidence from 27 RCTs shows TCM weight loss trials using pattern differentiation + biomarkers (e.g., HOMA-IR, adiponectin) achieve 27% greater BMI reduction vs. non-tailored approaches.
2026-03-12